Overview
- Addresses the regulatory science specific to complex drug products including quality, safety and clinical aspects
- Discusses raw materials, manufacturing. quality control, impurities, toxicity, immunogenicity, clinical trials and regulatory aspects
- Presents a roadmap for the future development of complex mixtures for medicinal use
Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series (AAPS, volume 32)
Access this book
Tax calculation will be finalised at checkout
Other ways to access
Table of contents (18 chapters)
Keywords
About this book
Editors and Affiliations
About the editors
Amy Rosenberg received her medical degree from Albert Einstein College of Medicine and is Board Certified in Internal Medicine. She was a post-doctoral fellow in Al Singer’s Laboratory in the NCI before coming to CBER, FDA in 1988. She became Director of the Division of Therapeutic Proteins, CBER/CDER in 2000. Her division (now DBRR3 in the Office of Biotechnology Products, CDER) regulates diverse protein therapeutics, including monoclonal antibodies and fusion proteins, enzyme replacement therapies, hematologic and somatic cell growth factors, and immunomodulatory agents. She has been a driving force in risk evaluation and mitigation pertaining to the immunogenicity of therapeutic proteins (Guidance for Industry: Immunogenicity Assessment for Therapeutic Protein Products) and in the elucidation and implementation of immune tolerance induction protocols in clinical settings. She previously co-edited the AAPS/Springer Book “Biobetters: Protein Engineering to Approach the Curative”.
Larry A. Walker is Director Emeritus of the National Center for Natural Products Research (NCNPR) at the University of Mississippi, having retired at the end of 2016 after 15 years as director. He has been a member of the faculty of the School of Pharmacy at Ole Miss for 37 years. He took his undergraduate pharmacy training at Mercer University (1975), and his doctorate in Pharmacology from Vanderbilt University School of Medicine in 1979, He has worked for much of his career on natural products drug discovery, pharmacology, toxicology and metabolism. Dr. Walker is a co-author of more than 200 papers in peer-reviewed journals in pharmacology, toxicology, and natural products discovery and development. He is a member of the American Society of Pharmacognosy, American Society of Pharmacology and Experimental Therapeutics, American Society of Microbiology, American Society of Tropical Medicine and Hygiene, American Association of Pharmaceutical Scientists. He has served on editorial boards of the Journal of Pharmacology and Experimental Therapeutics, Phytotherapy Research, and was the editor-in-chief of the Journal of Biomolecular Screening from 1999-2007. He received the University’s second Distinguished Research and Creative Achievement Award in 2009, and the School of Pharmacy’s Researcher of the Year Award in 2003. He works presently on development of strategic partnerships for the University of Mississippi, and as a senior science advisor with ElSohly Laboratories, Inc. in Oxford, MS, and consultant for pharmaceutical and botanical supplement industries.
Bibliographic Information
Book Title: The Science and Regulations of Naturally Derived Complex Drugs
Editors: Ram Sasisekharan, Sau L. Lee, Amy Rosenberg, Larry A. Walker
Series Title: AAPS Advances in the Pharmaceutical Sciences Series
DOI: https://doi.org/10.1007/978-3-030-11751-1
Publisher: Springer Cham
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: American Association of Pharmaceutical Scientists 2019
Hardcover ISBN: 978-3-030-11750-4Published: 03 May 2019
eBook ISBN: 978-3-030-11751-1Published: 23 April 2019
Series ISSN: 2210-7371
Series E-ISSN: 2210-738X
Edition Number: 1
Number of Pages: VI, 331
Number of Illustrations: 20 b/w illustrations, 41 illustrations in colour